MAPK10 and diffuse large B-cell lymphoma: These findings suggest that MAPK10 gene expression is epigenetically silenced through promoter hypermethylation in primary DLBCL samples, particularly within the ABC subtype, supporting its role as a tumor suppressor whose loss contributes to adverse clinical outcomes.